Comparison of the effects of 1,25-dihydroxyvitamin D3 on T lymphocyte subpopulations
β Scribed by William F. C. Rigby; Bruce Yirinec; Robert L. Oldershaw; Michael W. Fanger
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 445 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0014-2980
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Treatment of rheumatoid arthritis (RA) with cyclosporin A (CsA) has been successful, but the adverse effects of the drug have limited its use. We investigated the capacity of another immunosuppressive agent, 1,25dihydroxyvitamin D, [1,25(OH),D,], to augment the effect of CsA on in vitro T cell funct
Background: Vitamin D is essential for osteopenia therapy in Crohn's disease (CD). The active form of vitamin-D (aVD) is the 1,25(OH)2D. There are no data available whether aVD or plain vitamin-D (pVD) has any advantage in managing osteoporosis in CD or has any effect on the activity of the disease